Oxford Nanopore Technologies has teamed up with Cepheid to speed up infectious disease genomic analysis, blocking out recent ...

A new paper, released this week on bioRxiv, introduces hifiasm-ONT, a breakthrough genome assembly algorithm that enables partially phased, near telomere-to-telomere (T2T) assemblies1, using Oxford ...

Oxford Nanopore Technologies PLC ( ($GB:ONT) ) just unveiled an update. Oxford Nanopore Technologies PLC announced a transaction involving its ...

Oxford Nanopore Technologies, which develops and sells nanopore sequencing products, has announced the expansion of its Compatible Products Programme. These products are used for DNA or RNA sequencing ...

Oxford Nanopore Technologies, the company behind a new generation of sequencing-based molecular analysis technologies, and Cepheid, a leading molecular diagnostics company, today announced a strategic ...

Oxford Nanopore Technologies (LON:ONT – Free Report) had its price objective reduced by Berenberg Bank from GBX 282 ($3.64) to GBX 250 ($3.23) in a report issued on Wednesday, MarketBeat reports.

Other top genetic sequencing companies include PacBio, 10X Genomics, and Oxford Nanopore Technologies. Key findings are powered by ChatGPT and based solely off the content from this article.

ONT will report FY 2025 earnings on 03/24/2026 Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are ...

CEO of Oxford Nanopore Technologies. "By partnering to integrate our richer data, rapid insights, and accessible and affordable sequencing technology with Cepheid's GeneXpert architecture ...